Literature DB >> 33516128

Biomechanical properties of acellular scar ECM during the acute to chronic stages of myocardial infarction.

Bryn L Brazile1, J Ryan Butler1, Sourav S Patnaik1, Andrew Claude1, Raj Prabhu1, Lakiesha N Williams2, Karla L Perez3, Kytai T Nguyen3, Ge Zhang4, Pietro Bajona5, Matthias Peltz5, Yong Yang6, Yi Hong3, Jun Liao7.   

Abstract

After myocardial infarction (MI), the infarcted tissue undergoes dynamic and time-dependent changes. Previous knowledge on MI biomechanical alterations has been obtained by studying the explanted scar tissues. In this study, we decellularized MI scar tissue and characterized the biomechanics of the obtained pure scar ECM. By thoroughly removing the cellular content in the MI scar tissue, we were able to avoid its confounding effects. Rat MI hearts were obtained from a reliable and reproducible model based on permanent left coronary artery ligation (PLCAL). MI heart explants at various time points (15 min, 1 week, 2 weeks, 4 weeks, and 12 weeks) were subjected to decellularization with 0.1% sodium dodecyl sulfate solution for ~1-2 weeks to obtain acellular scar ECM. A biaxial mechanical testing system was used to characterize the acellular scar ECM under physiologically relevant loading conditions. After decellularization, large decrease in wall thickness was observed in the native heart ECM and 15 min scar ECM, implying the collapse of cardiomyocyte lacunae after removal of heart muscle fibers. For scar ECM 1 week, 2 weeks, and 4 weeks post infarction, the decrease in wall thickness after decellularization was small. For scar ECM 12 weeks post infarction, the reduction amount of wall thickness due to decellularization was minimal. We found that the scar ECM preserved the overall mechanical anisotropy of the native ventricle wall and MI scar tissue, in which the longitudinal direction is more extensible. Acellular scar ECM from 15 min to 12 weeks post infarction showed an overall stiffening trend in biaxial behavior, in which longitudinal direction was mostly affected and manifested with a decreased extensibility and increased modulus. This reduction trend of longitudinal extensibility also led to a decreased anisotropy index in the scar ECM from the acute to chronic stages of MI. The post-MI change in biomechanical properties of the scar ECM reflected the alterations of collagen fiber network, confirmed by the histology of scar ECM. In short, the reported structure-property relationship reveals how scar ECM biophysical properties evolve from the acute to chronic stages of MI. The obtained information will help establish a knowledge basis about the dynamics of scar ECM to better understand post-MI cardiac remodeling.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biaxial mechanical testing; Collagen fibers; Extracellular matrix; Myocardial infarction; Rat hearts; Scar tissue

Mesh:

Year:  2021        PMID: 33516128      PMCID: PMC8245054          DOI: 10.1016/j.jmbbm.2021.104342

Source DB:  PubMed          Journal:  J Mech Behav Biomed Mater        ISSN: 1878-0180


  80 in total

1.  Mechanically activated integrin switch controls alpha5beta1 function.

Authors:  Julie C Friedland; Mark H Lee; David Boettiger
Journal:  Science       Date:  2009-01-30       Impact factor: 47.728

2.  The stimulation of the cardiac differentiation of mesenchymal stem cells in tissue constructs that mimic myocardium structure and biomechanics.

Authors:  Jianjun Guan; Feng Wang; Zhenqing Li; Joseph Chen; Xiaolei Guo; Jun Liao; Nicanor I Moldovan
Journal:  Biomaterials       Date:  2011-05-12       Impact factor: 12.479

3.  Fiber orientation in the canine left ventricle during diastole and systole.

Authors:  D D Streeter; H M Spotnitz; D P Patel; J Ross; E H Sonnenblick
Journal:  Circ Res       Date:  1969-03       Impact factor: 17.367

4.  Experimental myocardial infarction. XIII. Sequential changes in left ventricular pressure-length relationships in the acute phase.

Authors:  F A Pirzada; E A Ekong; P S Vokonas; C S Apstein; W B Hood
Journal:  Circulation       Date:  1976-06       Impact factor: 29.690

Review 5.  Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.

Authors:  Kristine Y DeLeon-Pennell; Cesar A Meschiari; Mira Jung; Merry L Lindsey
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-18       Impact factor: 3.622

6.  Effects of reperfusion after coronary artery occlusion on post-infarction scar tissue.

Authors:  C M Connelly; W M Vogel; A W Wiegner; E L Osmers; O H Bing; R A Kloner; D M Dunn-Lanchantin; C Franzblau; C S Apstein
Journal:  Circ Res       Date:  1985-10       Impact factor: 17.367

7.  Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate.

Authors:  Nathaniel Huebsch; Praveen R Arany; Angelo S Mao; Dmitry Shvartsman; Omar A Ali; Sidi A Bencherif; José Rivera-Feliciano; David J Mooney
Journal:  Nat Mater       Date:  2010-04-25       Impact factor: 43.841

8.  Early increase in left ventricular compliance after myocardial infarction.

Authors:  J S Forrester; G Diamond; W W Parmley; H J Swan
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

Review 9.  Xenogeneic extracellular matrix as a scaffold for tissue reconstruction.

Authors:  Stephen F Badylak
Journal:  Transpl Immunol       Date:  2004-04       Impact factor: 1.708

10.  Function and fate of myofibroblasts after myocardial infarction.

Authors:  Neil A Turner; Karen E Porter
Journal:  Fibrogenesis Tissue Repair       Date:  2013-03-01
View more
  2 in total

1.  A Comparison of Fiber Based Material Laws for Myocardial Scar.

Authors:  Laura R Caggiano; Jeffrey W Holmes
Journal:  J Elast       Date:  2021-07-05       Impact factor: 1.742

2.  Ventricular stabilization with a customized decellularized cardiac ECM-based scaffold after myocardial infarction alters gene expression in a rodent LAD-ligation model.

Authors:  Hug Aubin; Lenard Rath; Alexandra Vey; Vera Schmidt; Mareike Barth; Elvira Weber; Artur Lichtenberg; Payam Akhyari
Journal:  Front Bioeng Biotechnol       Date:  2022-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.